Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells.
Rapid Response of Advanced Squamous Non-Small Cell Lung Cancer with Thrombocytopenia after First-Line Treatment with Pembrolizumab Plus Autologous Cytokine-Induced Killer Cells.
复制标题
DOI：
10.3389/fimmu.2015.00633
复制
发表时间：
2015
影响因子：
7.3
通讯作者：
Ren X
中科院分区：
文献类型：
--
作者：
Hui Z;Zhang X;Ren B;Li R;Ren X
我们首次提出了进展期鳞状非小细胞肺癌合并严重的血小板减少症的临床证据，在一线用培溴利珠单抗加自体细胞因子诱导的杀伤细胞治疗后显示出显著的改善。
We present the first clinical evidence of advanced squamous non-small cell lung cancer with severe thrombocytopenia showing dramatic improvement after first-line treatment with pembrolizumab plus autologous cytokine-induced killer cells.